此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

The Impact of Audiovisual Structured Patient Education Material in Improving Clinical and Behavioural Outcomes in Home-Based Cardiac Rehabilitation Programme Participants

2026年6月3日 更新者：University of Malaya

The Impact of Structured Patient Education Material in Improving Clinical and Behavioural Outcomes in Home-Based Cardiac Rehabilitation Programme Participants: A Randomised Controlled Trial Study

The goal of this clinical trial is to find out if newly developed, culturally adapted educational videos-sent through a mobile messaging app-can help people with coronary heart disease do better in a home-based cardiac rehabilitation program in Malaysia.

The main questions it aims to answer are:

  • Do the educational videos help participants improve their fitness?
  • Do the videos help participants better understand heart health and stick to a healthy lifestyle?

Researchers will compare the educational videos to existing standard educational materials to see if the video-based education is more helpful for supporting rehabilitation at home.

Participants will:

  • Take part in a 12-week home-based cardiac rehabilitation program
  • Receive either educational videos or standard education materials
  • Meet with the cardiac rehabilitation team every 4 weeks
  • Complete a treadmill exercise test, blood tests, and questionnaires before and after the program.

研究概览

地位

完全的

条件

干预/治疗

研究类型

介入性

注册 (实际的)

21

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 马来西亚
    • Kuala Lumpur
      • Kuala Lumpur、Kuala Lumpur、马来西亚、50603
        • Universiti Malaya Medical Centre

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Diagnosed as any form of ischaemic heart disease;
  • Classified as low to moderate risk based on American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) criteria through Exercise Stress Test (EST);
  • Cognitively intact and able to provide informed consent;
  • Literate and capable of utilising educational material;
  • Able to use and operate a smartphone with an exercise activity tracker (EAT).

Exclusion Criteria

- Classified as high risk according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

  • 主要用途：预防
  • 分配：随机化
  • 介入模型：并行分配
  • 屏蔽：四人间

武器和干预

参与者组/臂
干预/治疗
实验性的：Intervention
The intervention group received an audiovisual version of Structured Patient Education Materials during Cardiac Rehabilitation Programme Phase 2, which were delivered via WhatsApp.
其他：Audiovisual Structured Patient Education Materials
Bilingual (Malaysian and English language) Audiovisual Structured Patient Education Materials that are culturally adaptable on secondary prevention cardiac risk factors, self-care and exercise recommendations.
有源比较器：Control
The control group received the standard visual-based educational materials currently used in UMMC's Cardiac Rehabilitation Program Phase 2, which were delivered via WhatsApp.
其他：Standard Educational Materials
Standard visual-based educational materials currently used in Cardiac Rehabilitation Programme Phase 2, Universiti Malaya Medical Centre

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Change from Baseline in Cardiovascular Fitness Measured using metabolic equivalents (METs) at Completion of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

Metabolic equivalents (METs) obtained through the Exercise Stress Test (EST), employing the modified Bruce protocol.

Higher metabolic equivalents of task (METs) value indicate greater energy expenditure, higher physical intensity, and generally a better level of cardiorespiratory fitness. Conversely, a lower METs value indicates lower energy expenditure, lighter activity, and potentially a poorer functional capacity.
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Change from Baseline of Blood Glucose in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Blood glucose level through Glycated haemoglobin (HbA1c) in %
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Change from Baseline of Low-Density Lipoprotein Cholesterol in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Blood cholesterol through Low Density Lipoprotein (LDL) cholesterol in mmol/L
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Change from Baseline of Body Fat Composition in Clinical Parameters of Cardiovascular Risk Factors at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Body composition through waist circumference-to-height ratio (WHtR). Waist circumference is measured in centimetres (cm). Height is measured in centimetres (cm). Then, waist circumference-to-height will be combined and reported in a ratio.
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Smoking Cessation in Behavioural Parameter Related to Lifestyle Changes at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Smoking status and cessation were recorded weekly by self-reported statement (Smoking or Not).
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Medication Adherence in Behavioural Parameter Related to Lifestyle Changes at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Assessed at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Medication adherence was assessed at the end of Cardiac Rehabilitation Phase 2 by asking participants to indicate the likelihood of missing daily medication by using the options 'compliant', 'once a month', 'once a week', or 'more than once a week'.
Assessed at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Exercise Adherence Related to Lifestyle Changes at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Weekly assessment until the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Exercise adherence was tracked using the provided exercise activity tracker, with adherence defined as achieving an average of at least 150 minutes of exercise per week.
Weekly assessment until the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Change from Baseline in Cardiovascular Health Knowledge Assessment at 12 Weeks of Cardiac Rehabilitation Programme Phase 2
大体时间：Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
The Attitudes and Beliefs about Cardiovascular Disease (ABCD) risk questionnaire. Total scores range from 0 to 80 points. Higher scores indicate better overall CVD risk awareness and a greater health belief in one's capability to prevent cardiovascular disease.
Baseline and at the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
Understandability and Actionability of Education Materials at Completion of Cardiac Rehabilitation Programme Phase 2
大体时间：At the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks
The Patient Education Materials Assessment Tool (PEMAT) is a systematic method used to evaluate and score the understandability and actionability of patient education materials. Total score of 100%, with higher percentages indicating better quality of the educational material in understandability and actionability.
At the completion of Cardiac Rehabilitation Programme Phase 2 at 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

University of Malaya

调查人员

  • 首席研究员：Anwar Suhaimi、Universiti Malaya

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年7月19日

初级完成 (实际的)

2025年1月8日

研究完成 (实际的)

2025年1月16日

研究注册日期

首次提交

2025年11月20日

首先提交符合 QC 标准的

2026年6月3日

首次发布 (实际的)

2026年6月9日

研究记录更新

最后更新发布 (实际的)

2026年6月9日

上次提交的符合 QC 标准的更新

2026年6月3日

最后验证

2025年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • 2023717-12674
  • PV019-2020 (其他赠款/资助编号：UMSC C.A.R.E Fund Research Grant)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

不

IPD 计划说明

IPD will not be shared with outside researchers, as the informed consent forms for this study did not include a provision for future sharing of individual participant data beyond the initial research team. Therefore, IPD cannot be shared to protect participant autonomy.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅